During the past decade, Texas Cancer Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Cancer Care" #1 sponsor was "Amgen" with 1 trials, followed by "CTI BioPharma" with 1 trials sponsored, "Case Comprehensive Cancer Center" with 1 trials sponsored, "NCIC Clinical Trials Group" with 1 trials sponsored and "Novacea" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Cancer Care" #1 collaborator was "Aventis Pharmaceuticals" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Smith Kline Beecham" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Texas Cancer Care" are "Lung Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Breast Cancer" (1 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Texas Cancer Care" in a lesser frequency.

Most popular intervention types in "Texas Cancer Care" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (2 trials), "PANVAC™-VF" (1 trials), "arsenic trioxide" (1 trials), "calcitriol" (1 trials) and "carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Cancer Care" are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Cancer Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Texas Cancer Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Cancer Care, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".